Safe and Secure SSl Encryption
Licensing options
3000
USD
You can select one of these options upon checking out
Allows one individual to access the purchased report
Allows up to five individuals to access the purchased report
Allows all employees of an organization to access the purchased report. Internal sharing only
Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral
Use WELCOME to avail 10 % discount
North America: +1 201 793 8545 Europe: +44 20 8089 0049 Asia-Pacific: +91 7878231309
Email us on:- sales@bonafideresearch.com
Order Placed (27 September, 2023)
Notify To Team (27 September, 2023)
Report updation (28 September, 2023)
Report Quality Check (28 September, 2023)
Report Dispatch (29 September, 2023)
Hard Copy
Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer $1000 worth of FREE customization at the time of purchase
80% of the clinet request tailor made solution, how can we help you?
Avail customized purchase options to meet your exact research needs:
READY TO MIX MARKET HAS HELPED US TO UNDERSTAND PRODUCT, PRICE & VARIENTS OF ALL THE COMPETITION INCLUDING SMALL STARTUPS/REGIONAL PLAYERS.
CEO
Vivek Arora
BEING A STARTUP WE WERE NOT AWARE ABOUT E-COMMERCE LOGISTICS, THE REPORT HAS RESOLVED ALL OUR QUERIES. THE TEAM HAVE IN DEPTH KNOWLEDGE OF LOGISTICS. REMARKABLE!!
EXECUTIVE DIRECTOR
Rahul Roy
THE REPORT WAS GOOD FOR OUR STUDY, I WOULD STRONGLY RECOMMEND BONAFIDE RESEARCH. A VERY CUSTOMER CENTRIC AND APPROACHABLE TEAM.
SALES DIRECTOR
Arjun Prasad
THE COMPANY WHICH THOROUGHLY UNDERSTANDS INDIAN CONSUMER AND INDIAN MARKET. WE ARE REALLY HAPPY TO WORK WITH BONAFIDE RESEARCH
President
Manish Verma
Bonafide Research did an outstanding work on Global Hand Sanitizer project. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.
MARKETING DIRECTOR
Gautam Saxena
The study done by Bonafide Research was customized with all our needs. We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done.
PRODUCT MANAGER
Tom Stone
I’m glad I decided to work with you. Thankful to the team for the amazing coordination, it was indeed a good experience, would definitely recommend and come back for future prospects.
Associate Director
Mark Wood
Radiation therapy is the treatment of cancer and other diseases with radiation. Radiation in various forms is used to kill the cancer cells by preventing them from multiplying. Therapeutic radiology may be used to cure or control cancer, or to alleviate some of the symptoms associated with cancer. Publisher predicts that the global radiotherapy, nuclear medicine & radiopharmaceuticals market is estimated to touch a valuation of USD 30,329 million, registering a CAGR of 9.4% during the forecast period (2022-2028). The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global radiotherapy, nuclear medicine & radiopharmaceuticals market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the radiotherapy, nuclear medicine & radiopharmaceuticals industry. This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, and region. The global market for radiotherapy, nuclear medicine & radiopharmaceuticals can be segmented by product: radiopharmaceuticals, radiotherapy. According to the research, the radiopharmaceuticals segment had the largest share in the global radiotherapy, nuclear medicine & radiopharmaceuticals market. Radiotherapy, nuclear medicine & radiopharmaceuticals market is further segmented by application: bone metastasis, endocrine tumor, hyperthyroidism, lymphoma, oncology, others. Based on region, the radiotherapy, nuclear medicine & radiopharmaceuticals market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). By product: - radiopharmaceuticals - radiotherapy By application: - bone metastasis - endocrine tumor - hyperthyroidism - lymphoma - oncology - others By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The radiopharmaceuticals market is further segmented into diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals. Publisher research indicates that the diagnostic radiopharmaceuticals segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years. Furthermore, the radiopharmaceuticals by production method market has been categorized into cyclotron, generator, nuclear reactor. The radiotherapy market is further divided into external beam radiation therapy, internal radiation therapy or brachytherapy, systemic radiotherapy. The report explores the recent developments and profiles of key vendors in the Global Radiotherapy, Nuclear Medicine & Radiopharmaceuticals Market, including Accuray Inc., Advanced Accelerator Applications (Novartis International AG), Australian Nuclear Science and Technology Organisation (ANSTO), Bracco S.p.A., Cardinal Health, Inc., Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, ECZACIBASI-MONROL Nuclear Products Co., Elekta AB, GE Healthcare, IBA Molecular (IBAM), IRE - IRE ELiT, Jubilant Life Sciences Ltd., Lantheus Holdings, Inc., Nordion Inc, NTP Radioisotopes SOC Ltd., Varian Medical Systems Inc., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global radiotherapy, nuclear medicine & radiopharmaceuticals market. - To classify and forecast the global radiotherapy, nuclear medicine & radiopharmaceuticals market based on product, application, region. - To identify drivers and challenges for the global radiotherapy, nuclear medicine & radiopharmaceuticals market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global radiotherapy, nuclear medicine & radiopharmaceuticals market. - To identify and analyze the profile of leading players operating in the global radiotherapy, nuclear medicine & radiopharmaceuticals market. Why Choose This Report - Gain a reliable outlook of the global radiotherapy, nuclear medicine & radiopharmaceuticals market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.
Read More